Free Trial

Millennium Management LLC Raises Stock Position in agilon health, inc. (NYSE:AGL)

agilon health logo with Medical background

Millennium Management LLC grew its stake in agilon health, inc. (NYSE:AGL - Free Report) by 187.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,212,525 shares of the company's stock after buying an additional 4,706,357 shares during the quarter. Millennium Management LLC owned approximately 1.75% of agilon health worth $13,704,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the business. Barclays PLC boosted its stake in agilon health by 21.2% in the third quarter. Barclays PLC now owns 1,228,952 shares of the company's stock valued at $4,830,000 after acquiring an additional 214,830 shares in the last quarter. Inspire Investing LLC lifted its holdings in agilon health by 106.6% in the fourth quarter. Inspire Investing LLC now owns 217,550 shares of the company's stock valued at $413,000 after acquiring an additional 112,241 shares during the last quarter. First Citizens Bank & Trust Co. acquired a new position in agilon health during the fourth quarter worth $46,000. Empowered Funds LLC acquired a new stake in shares of agilon health in the fourth quarter valued at $97,000. Finally, Rhumbline Advisers increased its holdings in agilon health by 6.2% in the fourth quarter. Rhumbline Advisers now owns 419,587 shares of the company's stock valued at $797,000 after buying an additional 24,420 shares during the last quarter.

agilon health Stock Performance

AGL traded up $0.06 during midday trading on Wednesday, hitting $2.29. 802,124 shares of the company traded hands, compared to its average volume of 4,933,870. The company's 50-day moving average is $3.92 and its 200 day moving average is $3.18. The firm has a market capitalization of $945.88 million, a PE ratio of -2.43 and a beta of 0.38. agilon health, inc. has a 52 week low of $1.50 and a 52 week high of $7.73. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.01) by $0.04. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.50 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business's revenue was down 4.5% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.02) earnings per share. On average, research analysts expect that agilon health, inc. will post -0.59 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Royal Bank of Canada lifted their price target on shares of agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research report on Wednesday, February 26th. The Goldman Sachs Group boosted their price objective on shares of agilon health from $2.50 to $5.00 and gave the company a "neutral" rating in a research report on Thursday, May 8th. Citigroup raised shares of agilon health from a "neutral" rating to a "buy" rating and upped their price target for the stock from $3.25 to $5.00 in a research note on Friday, April 25th. Robert W. Baird reduced their price target on shares of agilon health from $6.00 to $5.00 and set a "neutral" rating for the company in a research report on Tuesday, April 15th. Finally, Wells Fargo & Company dropped their price target on shares of agilon health from $6.00 to $5.00 and set an "overweight" rating on the stock in a research note on Tuesday, May 13th. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $4.79.

Check Out Our Latest Research Report on agilon health

agilon health Profile

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines